| 1 | CNTNAP1, GLDN, LCCS11, LCCS7, NFASC, NRCAM
|
| Mutations in GLDN, Encoding Gliomedin, a Critical Component of the Nodes of Ranvier, Are Responsible for Lethal Arthrogryposis.
|
| Maluenda J, Manso C, Quevarec L, Vivanti A, Marguet F, Gonzales M, Guimiot F, Petit F, Toutain A, Whalen S, Grigorescu R, Coeslier AD, Gut M, Gut I, Laquerrière A, Devaux J, Melki J.
|
| Am J Hum Genet 99(4):928-933. doi: 10.1016/j.ajhg.2016.07.021.
2016
|
| 2 | GLDN
|
| Molecular Details of Olfactomedin Domains Provide Pathway to Structure-Function Studies.
|
| Hill SE, Donegan RK, Nguyen E, Desai TM, Lieberman RL.
|
| PLoS One 10(6):e0130888. doi: 10.1371/journal.pone.0130888.
2015
|
| 3 | GLDN
|
| Expression, purification, crystallization and preliminary X-ray crystallographic analysis of the extracellular olfactomedin domain of gliomedin.
|
| Han H, Kursula P.
|
| Acta Crystallogr F Struct Biol Commun 70(Pt 11):1536-9. doi: 10.1107/S2053230X14020305.
2014
|
| 4 | GLDN
|
| Antibodies to gliomedin cause peripheral demyelinating neuropathy and the dismantling of the nodes of Ranvier.
|
| Devaux JJ.
|
| Am J Pathol 181(4):1402-13. doi: 10.1016/j.ajpath.2012.06.034.
2012
|
| 5 | GLDN, NFASC, NRCAM
|
| Fibronectin type III-like domains of neurofascin-186 protein mediate gliomedin binding and its clustering at the developing nodes of Ranvier.
|
| Labasque M, Devaux JJ, Lévêque C, Faivre-Sarrailh C.
|
| J Biol Chem 286(49):42426-34. doi: 10.1074/jbc.M111.266353.
2011
|
| 6 | GLDN, NFASC, NRCAM
|
| A glial signal consisting of gliomedin and NrCAM clusters axonal Na+ channels during the formation of nodes of Ranvier.
|
| Feinberg K, Eshed-Eisenbach Y, Frechter S, Amor V, Salomon D, Sabanay H, Dupree JL, Grumet M, Brophy PJ, Shrager P, Peles E.
|
| Neuron 65(4):490-502. doi: 10.1016/j.neuron.2010.02.004.
2010
|
| 7 | GLDN
|
| Gliomedin mediates Schwann cell-axon interaction and the molecular assembly of the nodes of Ranvier.
|
| Eshed Y, Feinberg K, Poliak S, Sabanay H, Sarig-Nadir O, Spiegel I, Bermingham JR Jr, Peles E.
|
| Neuron 47(2):215-29. 2005
|
| 8 | GLDN
|
| Identification and characterization of CRG-L2, a new marker for liver tumor development.
|
| Graveel CR, Harkins-Perry SR, Acevedo LG, Farnham PJ.
|
| Oncogene 22(11):1730-6. 2003
|
| 9 | GLDN, CHARGE
|
| A patient with interstitial deletion of the short arm of chromosome 3 (pter-p21.2::p12-qter) and a CHARGE-like phenotype.
|
| Wieczorek D, et al.
|
| Am J Med Genet 69 : 413-417. 1997
|